| 1. | Vega FM, Ridley AJ. Rho GTPases in cancer cell biology[J]. FEBS Letters, 2008, 582 (14) : 2093-2101. | 
				                                                        
				                                                            
				                                                                | 2. | Boureux A, Vignal E, Faure S, et al. Evolution of the Rho family of ras-like GTPases in eukaryotes[J]. Mol Biol Evol, 2007, 24(1): 203-216. | 
				                                                        
				                                                            
				                                                                | 3. | Boettner B, Van Aelst L. The role of Rho GTPases in disease development[J]. Gene, 2002, 286(2): 155-174. | 
				                                                        
				                                                            
				                                                                | 4. | Villalonga P, Guasch RM, Riento K, et al. RhoE inhibits cell cycle progression and Ras-induced transformation[J]. Mol Cell Biol, 2004, 24(18): 7829-7840. | 
				                                                        
				                                                            
				                                                                | 5. | Roberts PJ, Mitin N, Keller PJ, et al. Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification[J]. J Biol Chem, 2008, 283(37): 25150-25163. | 
				                                                        
				                                                            
				                                                                | 6. | Madigan JP, Bodemann BO, Brady DC,et al. Regulation of Rnd3 localization and function by protein kinase C alpha-mediated phosphorylation[J]. Biochem J, 2009, 424(1): 153-161. | 
				                                                        
				                                                            
				                                                                | 7. | Riou P, Villalonga P, Ridley AJ. Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression[J]. Bioessays, 2010, 32(11): 986-992. | 
				                                                        
				                                                            
				                                                                | 8. | Cuiyan Z, Jie H, Fang Z, et al.Overexpression of RhoE in non-small cell lung cancer (nsclc) is associated with smoking and correlates with DNA copy number changes[J]. Cancer Biol Ther, 2007, 6(3): 335-342. | 
				                                                        
				                                                            
				                                                                | 9. | Klein1 RM, Andrew AE. Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in 3-D[J]. Cancer Res, 2009, 69(6): 2224-2233. | 
				                                                        
				                                                            
				                                                                | 10. | Rubenstein NM, Chan JF, Kim JY, et al. Rnd3/RhoE induces tight junction formation in mammary epithelial tumor cells[J]. Exp Cell Res, 2005, 305(1): 74-82. | 
				                                                        
				                                                            
				                                                                | 11. | Luo H, Zou J, Dong Z, et al. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma[J]. Biochem J, 2012, 442(2): 311-321. | 
				                                                        
				                                                            
				                                                                | 12. | Chen J, Zhou H, Li Q, et al. Epigenetic modification of RhoE expression in gastric cancer cells[J]. Oncol Rep, 2011, 25(1): 173-180. | 
				                                                        
				                                                            
				                                                                | 13. | Grise F, Sena S, Bidaud-Meynard A. Rnd3/RhoE is down-regulated in hepatocellular carcinoma and controls cellular invasion[J]. Hepatology, 2012, Jan 11. doi: 10.1002/hep.25568. | 
				                                                        
				                                                            
				                                                                | 14. | Bektic J, Pfeil K, Berger AP, et al. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis[J]. Prostate, 2005, 64(4): 332-340. | 
				                                                        
				                                                            
				                                                                | 15. | Li K, Lu Y, Liang J, et al. RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax[J]. Biochem Biophys Res Commun, 2009, 379(2): 212-216. | 
				                                                        
				                                                            
				                                                                | 16. | Belgiovine C, Frapolli R, Bonezzi K, et al. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells[J]. PLoS One, 2010, 5(11): e14154. |